glp-1 receptor agonist news drugs promise wider health benefits, but experts urge caution on use GLP-1 Receptor Agonists as Treatments

Dulaglutide in clinical trials AWARD (The Assessment of Weekly AdministRation) clinical trials were conducted to determine the efficacy of dulaglutide for achieving glycemic control in T2D and included a variety of phase 3 trials

Lancet Diabetes Endocrinol 5:341354 Athauda D, Maclagan K, Skene SS, et al (2017) Exenatide once weekly versus placebo in Parkinsons disease: a randomised, double-blind, placebo-controlled trial

For Medicare beneficiaries who have been priced out of GLP-1s for weight loss, $50 per fill is a deal

GLP-1 Receptor Agonists and Atherosclerosis Protection: The Vascular Endothelium Takes Center Stage

However, doctors may prescribe it off-label for weight management in appropriate candidates